Thanks Wayne,
Agree, the article certainly raised significant questions as did you. I keep coming back to what Paul Watt highlighted in the March Briefing Presentation last year. See my post at the time...
http://hotcopper.com.au/post_single.asp?fid=1&tid=1733483&msgid=10039325
There is a high probability that the second deal may relate to intracellular protein blockers in cancer.
Most definitely an interesting probability.
I must say though, I am still intrigued with Phylomer BEN_1312.
Regards,
Tony
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |